PURPOSE/ OBJECTIVES: To evaluate the feasibility, usability, and satisfaction of a survivorship care plan (SCP) and identify the optimum time for its delivery during the first 12 months after diagnosis. DESIGN: Prospective, descriptive, single-arm study. SETTING: A National Cancer Institute-designated cancer center in the southeastern United States. SAMPLE: 28 nonmetastatic colon cancer survivors within the first year of diagnosis and their primary care physicians (PCPs). METHODS: Regular screening identified potential participants who were followed until treatment ended. An oncology certified nurse developed the JourneyForward™ SCP, which then was delivered to the patient by the oncology nurse practitioner (NP) during a routine follow-up visit and mailed to the PCP. MAIN RESEARCH VARIABLES: Time to complete, time to deliver, usability, and satisfaction with the SCP. FINDINGS: During one year, 75 patients were screened for eligibility, 34 SCPs were delivered, and 28 survivors and 15 PCPs participated in the study. It took an average of 49 minutes to complete a surgery SCP and 90 minutes to complete a surgery plus chemotherapy SCP. Most survivors identified that before treatment ended or within the first three months was the preferred time to receive an SCP. CONCLUSIONS: The SCPs were well received by the survivors and their PCPs, but were too time and labor intensive to track and complete. IMPLICATIONS FOR NURSING: More work needs to be done to streamline processes that identify eligible patients and to develop and implement SCPs. Measuring outcomes will be needed to demonstrate whether SCPs are useful or not.
PURPOSE/ OBJECTIVES: To evaluate the feasibility, usability, and satisfaction of a survivorship care plan (SCP) and identify the optimum time for its delivery during the first 12 months after diagnosis. DESIGN: Prospective, descriptive, single-arm study. SETTING: A National Cancer Institute-designated cancer center in the southeastern United States. SAMPLE: 28 nonmetastatic colon cancer survivors within the first year of diagnosis and their primary care physicians (PCPs). METHODS: Regular screening identified potential participants who were followed until treatment ended. An oncology certified nurse developed the JourneyForward™ SCP, which then was delivered to the patient by the oncology nurse practitioner (NP) during a routine follow-up visit and mailed to the PCP. MAIN RESEARCH VARIABLES: Time to complete, time to deliver, usability, and satisfaction with the SCP. FINDINGS: During one year, 75 patients were screened for eligibility, 34 SCPs were delivered, and 28 survivors and 15 PCPs participated in the study. It took an average of 49 minutes to complete a surgery SCP and 90 minutes to complete a surgery plus chemotherapy SCP. Most survivors identified that before treatment ended or within the first three months was the preferred time to receive an SCP. CONCLUSIONS: The SCPs were well received by the survivors and their PCPs, but were too time and labor intensive to track and complete. IMPLICATIONS FOR NURSING: More work needs to be done to streamline processes that identify eligible patients and to develop and implement SCPs. Measuring outcomes will be needed to demonstrate whether SCPs are useful or not.
Entities:
Keywords:
colon cancer; communication; survivorship; survivorship care plans; transitions
Authors: D Howell; T F Hack; T K Oliver; T Chulak; S Mayo; M Aubin; M Chasen; C C Earle; A J Friedman; E Green; G W Jones; J M Jones; M Parkinson; N Payeur; C M Sabiston; S Sinclair Journal: J Cancer Surviv Date: 2012-07-10 Impact factor: 4.442
Authors: Leigh Anne Faul; Brian Rivers; David Shibata; Ione Townsend; Patricia Cabrera; Gwendolyn P Quinn; Paul B Jacobsen Journal: J Psychosoc Oncol Date: 2012
Authors: Arnold L Potosky; Paul K J Han; Julia Rowland; Carrie N Klabunde; Tenbroeck Smith; Noreen Aziz; Craig Earle; John Z Ayanian; Patricia A Ganz; Michael Stefanek Journal: J Gen Intern Med Date: 2011-07-22 Impact factor: 5.128
Authors: Ted A Skolarus; Margaret Holmes-Rovner; Laurel L Northouse; Angela Fagerlin; Carol Garlinghouse; Raymond Y Demers; David R Rovner; May Darwish-Yassine; John T Wei Journal: Urol Oncol Date: 2011-07-20 Impact factor: 3.498
Authors: Christine E Hill-Kayser; Carolyn C Vachani; Margaret K Hampshire; Gloria Di Lullo; Linda A Jacobs; James M Metz Journal: Cancer Date: 2013-08-06 Impact factor: 6.860
Authors: SarahMaria Donohue; Mary E Sesto; David L Hahn; Kevin A Buhr; Elizabeth A Jacobs; James M Sosman; Molly J Andreason; Douglas A Wiegmann; Amye J Tevaarwerk Journal: J Oncol Pract Date: 2015-03-24 Impact factor: 3.840
Authors: Rebecca E Hill; Claire E Wakefield; Richard J Cohn; Joanna E Fardell; Mary-Ellen E Brierley; Emily Kothe; Paul B Jacobsen; Kate Hetherington; Rebecca Mercieca-Bebber Journal: Oncologist Date: 2019-10-25
Authors: Rebecca E Hill; Claire E Wakefield; Richard J Cohn; Joanna E Fardell; Mary-Ellen E Brierley; Emily Kothe; Paul B Jacobsen; Kate Hetherington; Rebecca Mercieca-Bebber Journal: Oncologist Date: 2019-10-25